Mesothelioma

R. Huber (Munich, Germany)

Source: ERS Skills Course 2016
Number: 15

PDF journal article, handout or slidesPDF journal article, handout or slides

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Huber (Munich, Germany). Mesothelioma. ERS Skills Course 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Malignant Mesothelioma: Place for thoracoscopy
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014

Malignant Mesothelioma: Place for thoracoscopy
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014

Mesothelioma: an update
Source: Breathe 2011; 8: 45-52
Year: 2011


Role of fibulin-3 in the diagnosis of malignant mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Malignant Mesothelioma: place for thoracoscopy
Source: ERS Skills Course 2016
Year: 2016

Malignant pleural mesothelioma: A retrospective analysis of 32 cases
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Impact of angiopoietin-1 in mesothelioma progression
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013

Volume quantification of malignant pleural mesothelioma
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Pleural mesothelioma: Our experience in 132 cases
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Haematologic parameters and their prognostic impact in malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline
Source: ERS Webinars 2019 - Relevant aspects of the new ERS/EACTS/ESTS/ESTRO Pleural Mesothelioma Guideline
Year: 2019


Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Diagnostic yield of combined epidemiological and radiological data in Malignant Pleural Mesothelioma: A Pilot Study
Source: International Congress 2019 – Indoor and outdoor air quality considerations
Year: 2019


Malignant mesothelioma
Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques
Year: 2018

Malignant mesothelioma diagnosed at medical thoracoscopy – A service review
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Thoracoscopy: Outcomes in non-diagnostic procedures
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013